CMS’s new national payment rate and unique reimbursement codes signal a transformative shift in radiotherapy reimbursement, removing barriers to the clinical adoption of RefleXion’s SCINTIX biology-guided radiotherapy. The breakthrough approach, utilizing emissions from cancer…
Continue Reading
The newly inaugurated MRI-guided proton therapy prototype in Dresden signals a paradigm shift in cancer treatment. This innovative system, merging a full-body MRI with real-time imaging and proton therapy, offers unprecedented accuracy. Pioneered by…
Continue Reading
The newly inaugurated MRI-guided proton therapy prototype in Dresden signals a paradigm shift in cancer treatment. This innovative system, merging a full-body MRI with real-time imaging and proton therapy, offers unprecedented accuracy. Pioneered by…
Continue Reading
The newly inaugurated MRI-guided proton therapy prototype in Dresden signals a paradigm shift in cancer treatment. This innovative system, merging a full-body MRI with real-time imaging and proton therapy, offers unprecedented accuracy. Pioneered by…
Continue Reading
What You Should Know:
– Debiopharm, a leading independent biopharmaceutical company, and ThinkingNodeLife.ai (TNL), a pioneer in AI-powered drug discovery, today announced a groundbreaking partnership to propel the development of a cutting-edge cancer drug.
– This…
Continue Reading
Lance Hill, CEO of Within3
The cancer market for the pharma industry accounts for about a third of their product pipeline. With oncology drug sales set to top $390 billion by 2027, life science companies…
Continue Reading
Oscar Wilde once wrote, “Life imitates art far more than art imitates life.” My experience with cancer treatment mirrors Pixar’s parody of how insurance works in The Incredibles. And listen—whether or not you see The…
Continue Reading
What You Should Know:
– Absci Corporation (ABSI), a pioneer in using generative AI to discover antibodies, and AstraZeneca, a global biopharmaceutical leader, announced a collaboration today to develop an AI-designed antibody for cancer.
– This…
Continue Reading
TeleDaaS, a Dosimetry-as-a-Service pioneer, unveils its breakthrough platform at #RSNA2023. Specializing in precision dosimetry for CROs and pharmaceuticals, TeleDaaS integrates seamlessly with imaging workflows to advance cancer treatment research. Led by Dr. Mark Crockett,…
Continue Reading
Careology and Nuffield Health, the UK’s largest healthcare charity, have extended their partnership to provide people undergoing cancer treatment access to advanced digital cancer care technology at 12 Nuffield Health hospitals across the UK. During…
Continue Reading
